Want to throw out another possibility I've been contemplating for discussion. With Herantis/Renishaw verifying device and procedure safety, I wonder if there might be a three way partnership combo coming where MANF and a MANF/CDNF combo are added in the trial.
Like we could offer them a position in MANFs PD success for them paying for the trial costs
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links